A Study of Barzolvolimab in Patients With Prurigo Nodularis
Condition: Prurigo Nodularis · Sponsor: Celldex Therapeutics
About this study
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (72)
| Total Dermatology | Birmingham, Alabama, United States | — |
| Cahaba Dermatology Skin Health Center | Birmingham, Alabama, United States | — |
| Investigate MD, LLC | Scottsdale, Arizona, United States | — |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | — |
| Center for Dermatology Clinical Research, Inc | Fremont, California, United States | — |
| Profound Research LLC | Oceanside, California, United States | — |
| Empire Clinical Research | Pomona, California, United States | — |
| University of California San Francisco | San Francisco, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| Dermatology Institute & Skin Care Center | Santa Monica, California, United States | — |
| Focus Clinical Research | West Hills, California, United States | — |
| Encore Medical Research Boynton Beach | Boynton Beach, Florida, United States | — |
+ 60 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06366750